Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability

International Journal of Pharmaceutics

Volumn 429, Issue 1-2, 2012, Pages 104-112

  Kapse, Sonali V ^a   Gaikwad, Rajiv V ^b   Samad, Abdul ^b   Devarajan, Padma V ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b BOMBAY VETERINARY COLLEGE   (India)

Author keywords

Bioavailability; In situ nanoprecipitation; Polymeric nanoparticles; Scintigraphy; Self nanoprecipitating preconcentrate; Tamoxifen citrate

Indexed keywords

DRUG VEHICLE; NANOPARTICLE; NANOSPHERE; POLYMER; POLYSORBATE 80; POVIDONE; SURFACTANT; TAMOXIFEN CITRATE; TECHNETIUM 99M;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DILUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG LABELING; DRUG POTENTIATION; DRUG RELEASE; FEMALE; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SURFACE TENSION; SUSPENSION; SUSTAINED DRUG RELEASE; TEMPERATURE; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BIOLOGICAL AVAILABILITY; CHEMICAL PRECIPITATION; DIOCTYL SULFOSUCCINIC ACID; DRUG DESIGN; FEMALE; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PARTICLE SIZE; POLYSORBATES; POVIDONE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SURFACE TENSION; SURFACE-ACTIVE AGENTS; TAMOXIFEN; TEMPERATURE;

EID: 84859605350     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.02.042     Document Type: Article

References (43)

1. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
2. A.K. Andrianov, and L.G. Payne Polymeric carriers for oral uptake of microparticulates Adv. Drug Deliv. Rev. 34 1998 155 170 (Pubitemid 28535110)
3. J.L. Arias, A.G. Gallo, Á.V. Delgado, and M.A. Ruiz Kollidon® SR colloidal particles as vehicles for oral morphine delivery in pain treatment Colloids and Surfaces B 70 2009 207 212
4. J.L. Arias, A.G. Gallo, Á.V. Delgado, and V. Gallardo Study of the stability of Kollidon® SR suspensions for pharmaceutical applications Colloid Surface A 338 2009 107 113
5. 131I labeling of tamoxifen and biodistribution studies in rats Appl. Radiat. Isot. 66 2008 178 187 (Pubitemid 350256950)
6. A. Bogner, G. Thollet, D. Basset, P.H. Jouneau, and C. Gauthier Wet STEM: a new development in environmental SEM for imaging nano-objects included in a liquid phase Ultramicroscopy 104 2005 290 301 (Pubitemid 40982472)
7. M.M. Buckley, and K.L. Goa Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use Drugs 37 1989 451 490
8. J.S. Chawla, and M.M. Amiji Biodegradable poly(caprolactone) nanoparticles for tumor targeted delivery of tamoxifen Int. J. Pharm. 249 2002 127 138 (Pubitemid 35333439)
9. D.R. Ciocca, and L.M. Vargas Estrogen receptors in human nontarget tissues: biological and clinical implications Endocrine Rev. 16 1995 35 62
10. M.A. Clark, M.A. Jepson, and B.H. Hirst Exploiting M cells for drug and vaccine delivery Adv. Drug Deliv. Rev. 50 2001 81 106 (Pubitemid 32727278)
11. G. Coppi, and V. Iannuccelli Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system Int. J. Pharm. 367 2009 127 132
12. C.A. Coutts-Lendon, N.A. Wright, E.V. Mieso, and J.L. Koenig The use of FT-IR imaging as an analytical tool for the characterization of drug delivery systems J. Control. Release 93 2003 223 248 (Pubitemid 37485946)
13. P. Couvreur, and C. Vauthier Nanotechnology: intelligent design to treat complex disease Pharm. Res. 23 2006 1417 1450 (Pubitemid 43993807)
14. W.Y. Dong, M. Körber, V.L. Esguerra, and R. Bodmeier Stability of poly(d,l-lactide-co-glycolide) and leuprolide acetate in in situ forming drug delivery systems J. Control. Release 115 2006 158 167 (Pubitemid 44537494)
15. K.L. Erickson, T.E. Bostrom, and R.L. Frost A study of structural memory effects in synthetic hydrotalcites using environmental SEM Mater. Lett. 59 2005 226 229
16. O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P.W. Kantoff, J.P. Richie, and R. Langer Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo PNAS 103 2006 6315 6320
17. P. Fasinu, V. Pillay, V.M.K. Ndesendo, L.C. du Toit, and Y.E. Choonara Diverse approaches for the enhancement of oral drug bioavailability Biopharm. Drug Dispos. 32 2011 185 209
18. T. Feczko, J. Toth, and J. Gyenis Comparison of the preparation of PLGA-BSA nano- and microparticles by PVA, poloxamer and PVP Colloid Surface A 319 2008 188 195 (Pubitemid 351609401)
19. A.T. Florence The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual Pharm. Res. 14 1997 259 266 (Pubitemid 27160935)
20. T.M. Goppert, and R.H. Muller Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN) Eur. J. Pharm. Biopharm. 60 2005 361 372 (Pubitemid 40922833)
21. N. Hussain, V. Jaitley, and A.T. Florence Recent advances in the understanding of uptake of microparticulate across the gastrointestinal lymphatics Adv. Drug Deliv. Rev. 50 2001 107 142 (Pubitemid 32727279)
22. R. Jain The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 2000 2475 2490
23. A.K. Jain, N.K. Swarnakar, C. Godugu, R.P. Singh, and S. Jain The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen Biomaterials 32 2011 503 515
24. O.L. Kon An antiestrogen binding protein in human tissues J. Biol. Chem. 258 1983 3173 3177
25. M. Körber, and R. Bodmeier Development of an in situ forming PLGA drug delivery system I. Characterization of a non-aqueous protein precipitation Eur. J. Pharm. Sci. 35 2008 283 292
26. H. Kranz, and R. Bodmeier A novel in situ forming drug delivery system for controlled parenteral drug delivery Int. J. Pharm. 332 2007 107 114 (Pubitemid 46227772)
27. H. Kranz, G.A. Brazeau, J. Napaporn, R.L. Martin, W. Millard, and R. Bodmeier Myotoxicity studies of injectable biodegradable in situ forming drug delivery systems Int. J. Pharm. 212 2001 11 18 (Pubitemid 32121946)
28. A. Laskin, J.P. Cowin, and M.J. Iedema Analysis of individual environmental particles using modern methods of electron microscopy and X-ray microanalysis J. Electron Microsc. Relat. Phenom. 150 2006 260 274 (Pubitemid 41737453)
29. J. Li, F. Chen, C. Hu, L. He, K. Yan, L. Zhou, and W. Pan Optimized preparation of in situ forming microparticles for the parenteral delivery of vinpocetine Chem. Pharm. Bull. 56 2008 796 801 (Pubitemid 351872246)
30. X. Luan, and R. Bodmeier In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters Eur. J. Pharm. Sci. 27 2006 143 149 (Pubitemid 41831249)
31. X. Luan, and R. Bodmeier Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems J. Control. Release 110 2006 266 272 (Pubitemid 41827479)
32. J.G. McVie, G.P. Simonetti, D. Stevenson, R.J. Brigss, P.J. Guelen, and D. de Vos The bioavailability of Tamoplex (Tamoxifen). Part 1. A pilot study Methods Find. Exp. Clin. Pharmacol. 8 1986 505 512 (Pubitemid 16007740)
33. M.-C. Chen, H.-S. Wong, K.-J. Lin, H.-L. Chen, S.-P. Wey, K. Sonaje, Y.-H. Lin, C.-Y. Chu, and H.-W. Sung The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin Biomaterials 30 2009 6629 6637
34. H.A. Merchant, H.M. Shoaib, J. Tazeen, and R.I. Yousuf Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note AAPS PharmSci. Tech. 7 2006 E1 E6
35. B.J. Palla, and D.O. Shah Stabilization of high ionic strength slurries using surfactant mixtures: molecular factors that determine optimal stability J. Colloid Interf. Sci. 202 2002 143 152 (Pubitemid 36164586)
36. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347 (Pubitemid 36297053)
37. A. Pongpeerapat, C. Wanawongthai, Y. Tozuka, K. Moribe, and K. Yamamotoa Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture Int. J. Pharm. 352 2008 309 316
38. M.J. Rosen, T. Gao, Y. Nakatsuji, and A. Masuyama Synergism in binary mixtures of surfactants 12. Mixtures containing surfactants with two hydrophilic and two or three hydrophobic groups Colloid Surface A 88 1994 1 11
39. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinsk Biodegradable polymeric nanoparticles as drug delivery devices J. Control. Release 70 2001 1 20 (Pubitemid 32144788)
40. J.J. Tukker, M.A.Blankenstein, and J.W. Nortier Comparison of bioavailability in man of tamoxifen after oral and rectal administration J. Pharm. Pharmacol. 38 1986 888 892 (Pubitemid 17200289)
41. M. Weert, R. Hof, J. Weerd, R.M.A. Heeren, G. Posthuma, W.E. Hennink, and D.J.A. Crommelin Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques J. Control. Release 68 2000 31 40 (Pubitemid 30409973)
42. W.B. Winborn, P.J. Sheridan, and H.C. McGill Sex steroids in the stomach, liver, pancrease, and gastrointestinal tract of the baboon Gastroenterology 92 1987 23 32 (Pubitemid 17207657)
43. Q. Zhang, G. Yie, Y. Li, Q. Yang, and T. Nagai Studies on the cyclosporin A loaded stearic acid nanoparticles Int. J. Pharm. 200 2000 153 159 (Pubitemid 30364902)